Skip to main content
OpenTrials
Completed

NCT Number: NCT03447327

Outcome of Single Burr Hole Under Local Anaesthesia in the Management of Chronic Subdural Hematoma

Aim of the work: Is to evaluate the prognosis of single burr hole under local anesthesia in management of CSDH according to clinical picture, risk factors, and age.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Patients and methods: We studied 67 consecutive patients with CSDH operated by single burr hole craniostomy under local anaesthesia from Mars, 2014 to February, 2015 in Zagazig University Hospitals according to the aetiology, clinical picture, risk factors, and complications.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

chronic subdural hematoma above 19 years old -

Exclusion criteria

age below 19 years acute subduralhematoma uncoperative patients

-

Treatment and study plan

single burr hole

Procedure

patients with CSDH operated by single burr hole craniostomy under local anaesthesia

Primary outcomes

  1. Glasgow Outcome Scale

    Time frame: 6 months postoperative

    The Glasgow Outcome Scale was used as measuremabilityent for neurological oucome after surgery.The patients were classified as as dead, persistant vegetative state, severe disability, moderate disability, and mild dis

Sponsors and collaborators

Lead sponsor

Zagazig University

Other Gov

Registry information

Important dates

Study start
2014
Primary completion
2015
Study completion
2015
First posted
Feb 27, 2018
Registry last updated
Feb 27, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.